Log in

Celsion Stock Forecast, Price & News

+0.01 (+1.71 %)
(As of 09/28/2020 03:01 AM ET)
Today's Range
Now: $0.73
50-Day Range
MA: $0.94
52-Week Range
Now: $0.73
Volume460,000 shs
Average Volume1.67 million shs
Market Capitalization$24.29 million
P/E RatioN/A
Dividend YieldN/A
Celsion Corporation, a development stage oncology drug company, focuses on the development and commercialization of directed chemotherapies, DNA-mediated immunotherapy, and RNA based therapies for the treatment of cancer. Its lead product candidate is ThermoDox, a liposomal encapsulation of doxorubicin that is in Phase III clinical trial for treating primary liver cancer. The company is also developing GEN-1, a DNA-based immunotherapeutic product for the localized treatment of ovarian and brain cancers. Celsion Corporation was founded in 1982 and is headquartered in Lawrenceville, New Jersey.
Read More
Celsion logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.29 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolNASDAQ:CLSN



Sales & Book Value

Annual Sales$500,000.00
Book Value$0.63 per share


Net Income$-16,850,000.00
Net Margins-3,795.80%


Market Cap$24.29 million
Next Earnings Date11/12/2020 (Estimated)
+0.01 (+1.71 %)
(As of 09/28/2020 03:01 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CLSN News and Ratings via Email

Sign-up to receive the latest news and ratings for CLSN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Celsion (NASDAQ:CLSN) Frequently Asked Questions

How has Celsion's stock been impacted by Coronavirus (COVID-19)?

Celsion's stock was trading at $0.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CLSN stock has decreased by 26.2% and is now trading at $0.7310.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Celsion?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Celsion in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Celsion

When is Celsion's next earnings date?

Celsion is scheduled to release its next quarterly earnings announcement on Thursday, November 12th 2020.
View our earnings forecast for Celsion

How were Celsion's earnings last quarter?

Celsion Co. (NASDAQ:CLSN) released its earnings results on Friday, August, 14th. The biotechnology company reported ($0.18) EPS for the quarter, missing the consensus estimate of ($0.14) by $0.04. Celsion had a negative return on equity of 107.78% and a negative net margin of 3,795.80%.
View Celsion's earnings history

When did Celsion's stock split? How did Celsion's stock split work?

Celsion shares reverse split on Tuesday, May 30th 2017. The 1-14 reverse split was announced on Friday, May 26th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 26th 2017. An investor that had 100 shares of Celsion stock prior to the reverse split would have 7 shares after the split.

What price target have analysts set for CLSN?

2 brokers have issued 12 month price targets for Celsion's stock. Their forecasts range from $4.00 to $4.00. On average, they expect Celsion's share price to reach $4.00 in the next year. This suggests a possible upside of 447.2% from the stock's current price.
View analysts' price targets for Celsion

Who are some of Celsion's key competitors?

What other stocks do shareholders of Celsion own?

Who are Celsion's key executives?

Celsion's management team includes the following people:
  • Mr. Michael H. Tardugno, Exec. Chairman, Pres & CEO (Age 68)
  • Mr. Jeffrey W. Church CPA, CPA, CFO, Exec. VP & Corp. Sec. (Age 62)
  • Dr. Khursheed Anwer, Exec. VP & Chief Scientific Officer (Age 59)
  • Dr. Nicholas Borys, Exec. VP & Chief Medical Officer (Age 60)
  • Mr. Timothy J. Tumminello, Chief Accounting Officer & Controller (Age 61)

What is Celsion's stock symbol?

Celsion trades on the NASDAQ under the ticker symbol "CLSN."

Who are Celsion's major shareholders?

Celsion's stock is owned by a variety of retail and institutional investors. Top institutional investors include Worth Venture Partners LLC (0.54%), Envestnet Asset Management Inc. (0.08%), Park Avenue Securities LLC (0.08%), Total Investment Management Inc. (0.08%), Charles Schwab Investment Management Inc. (0.05%) and Two Sigma Advisers LP (0.04%). Company insiders that own Celsion stock include Alberto R Martinez Jr, Frederick J Fritz, Jeffrey Wayne Church, Michael H Tardugno and Robert W Hooper.
View institutional ownership trends for Celsion

Which institutional investors are buying Celsion stock?

CLSN stock was purchased by a variety of institutional investors in the last quarter, including Worth Venture Partners LLC, Park Avenue Securities LLC, Envestnet Asset Management Inc., Total Investment Management Inc., Charles Schwab Investment Management Inc., and Two Sigma Advisers LP. Company insiders that have bought Celsion stock in the last two years include Alberto R Martinez Jr, Frederick J Fritz, Jeffrey Wayne Church, Michael H Tardugno, and Robert W Hooper.
View insider buying and selling activity for Celsion

How do I buy shares of Celsion?

Shares of CLSN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Celsion's stock price today?

One share of CLSN stock can currently be purchased for approximately $0.73.

How big of a company is Celsion?

Celsion has a market capitalization of $24.29 million and generates $500,000.00 in revenue each year. The biotechnology company earns $-16,850,000.00 in net income (profit) each year or ($0.91) on an earnings per share basis. Celsion employs 29 workers across the globe.

What is Celsion's official website?

The official website for Celsion is www.celsion.com.

How can I contact Celsion?

Celsion's mailing address is 997 LENOX DRIVE SUITE 100, LAWRENCEVILLE NJ, 08648. The biotechnology company can be reached via phone at 609-896-9100 or via email at [email protected]

This page was last updated on 9/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.